Regulatory strategy defines the overall plan to market, including qualification and classification of a medical device. Clinical strategy builds on this foundation by structuring how evidence is generated and demonstrated.

Together, regulatory and clinical strategies shape key business decisions – impacting timelines, investment needs, risk, and market positioning.

In this session, we will explore how these perspectives connect in practice – linking intended purpose and claims to clinical evaluation, evidence gap analysis, and decisions on clinical investigations and study design.